Abstract:Abstract Background Acquired resistance of 5-fluorouracil (5-FU) remains a clinical challenge in colorectal cancer (CRC), and efforts to develop targeted agents to reduce resistance have not yielded success. Metabolic reprogramming is a key cancer hallmark and confers several tumor phenotypes including chemoresistance. Glucose metabolic reprogramming events of 5-FU resistance in CRC has not been evaluated, and whether abnormal glucose metabolism could impart 5-FU resistance in CRC is also poorly defined. Methods Three separate acquired 5-FU resistance CRC cell line models were generated, and glucose metabolism was assessed by measuring glucose and lactate utilization, RNA and protein expressions of glucose metabolism-related enzymes and changes of intermediate metabolites of glucose metabolite pool. The protein levels of hypoxia inducible factor 1α (HIF-1α) in primary tumors and circulating tumor cells of CRC patients were detected by immunohistochemistry and immunofluorescence. Stable HIF1A knockdown in cell models was established with a lentiviral system. The influence of both HIF1A gene knockdown and pharmacological inhibition on 5-FU resistance in CRC was evaluated in cell models in vivo and in vitro. Results The abnormality of glucose metabolism in 5-FU-resistant CRC were described in detail. The enhanced glycolysis and pentose phosphate pathway in CRC were associated with increased HIF-1α expression. HIF-1α-induced glucose metabolic reprogramming imparted 5-FU resistance in CRC. HIF-1α showed enhanced expression in 5-FU-resistant CRC cell lines and clinical specimens, and increased HIF-1α levels were associated with failure of fluorouracil analog-based chemotherapy in CRC patients and poor survival. Upregulation of HIF-1α in 5-FU-resistant CRC occurred through non-oxygen-dependent mechanisms of reactive oxygen species-mediated activation of PI3K/Akt signaling and aberrant activation of β-catenin in the nucleus. Both HIF-1α gene knock-down and pharmacological inhibition restored the sensitivity of CRC to 5-FU. Conclusions HIF-1α is a potential biomarker for 5-FU-resistant CRC, and targeting HIF-1a in combination with 5-FU may represent an effective therapeutic strategy in 5-FU-resistant CRC.

Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells.

Fibroblast-Derived Exosomes Contribute to Chemoresistance Through Priming Cancer Stem Cells in Colorectal Cancer.

Exosomes Derived from 5-Fluorouracil-resistant Colon Cancer Cells Are Enriched in GDF15 and Can Promote Angiogenesis.

Exosomal Wnt-induced Dedifferentiation of Colorectal Cancer Cells Contributes to Chemotherapy Resistance

Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil

Synergistic Effects And Mechanism Of Danshen Injection In Combination With Chemotherapy And Antiangiogenic Therapy For Colon Cancer

Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines.

HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance

Prostaglandin F 2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F 2α -dependent and F 2α -independent mechanism

Hypoxic Pancreatic Cancer Derived Exosomal MiR-30b-5p Promotes Tumor Angiogenesis by Inhibiting GJA1 Expression

PTOV1‐AS1 desensitizes colorectal cancer cells to 5‐FU through depressing miR‐149‐5p to activate the positive feedback loop with Wnt/β‐catenin pathway

Prosomes and Heat Shock Complexes Indrosophila Melanogastercells:

Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells

Dipeptidyl Peptidase-4 modulates Long-chain Acyl-CoA synthetase 4 to Promote Lipid Peroxidation and Regulate Ferroptosis in Pancreatic Cancer

FOXF1 Promotes Angiogenesis and Accelerates Bevacizumab Resistance in Colorectal Cancer by Transcriptionally Activating VEGFA

Hypoxic Colorectal Cancer-Secreted Exosomes Deliver Mir-210-3p to Normoxic Tumor Cells to Elicit a Protumoral Effect.

Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness

ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer

Stem cell factor modulates HIF‐1α levels and diminishes 5‐FU sensitivity in 5‐FU resistant pancreatic cells by altering the anabolic glucose metabolism

Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes

DKK4 Enhances Resistance to Chemotherapeutics 5-Fu and YN968D1 in Colorectal Cancer Cells.